Methods for reducing fecal shedding

Details Methods for reducing fecal shedding Methods for reducing fecal shedding

2008-05-13

2008-05-13

Minnifield, N. M. (Department: 1645)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Bacterium or component thereof or substance produced by said...

C424S184100, C424S241100, C424S255100, C424S257100, C424S258100, C424S259100, C424S260100, C424S203100, C424S823000, C514S002600, C514S012200

Reexamination Certificate

active

07371393

ABSTRACT:
The present invention provides methods for reducing shedding in an animal. Generally, the method includes administcriirn to an animal a composition including siderophore receptor polypeptides and porins from gram negative microbes, and preferably, lipopolysaccarhide at a concentration of no greater than about 10.0 endotoxin units per milliliter.

REFERENCES:
patent: 4167560 (1979-09-01), Wohler, Jr.
patent: 4452775 (1984-06-01), Kent
patent: 4626416 (1986-12-01), DeVoe et al.
patent: 4663161 (1987-05-01), Mannino et al.
patent: 4681761 (1987-07-01), Mietzner et al.
patent: 4748018 (1988-05-01), Stolle et al.
patent: 4871488 (1989-10-01), Mannino et al.
patent: 4981685 (1991-01-01), Healey
patent: 5141743 (1992-08-01), Schryvers
patent: 5292869 (1994-03-01), Schryvers
patent: 5439808 (1995-08-01), Blake et al.
patent: 5534256 (1996-07-01), Potter et al.
patent: 5538733 (1996-07-01), Emery et al.
patent: 5587166 (1996-12-01), Donachie
patent: 5688682 (1997-11-01), Mulks et al.
patent: 5830479 (1998-11-01), Emery et al.
patent: 5885589 (1999-03-01), Foged et al.
patent: 5906826 (1999-05-01), Emery et al.
patent: 6027736 (2000-02-01), Emery et al.
patent: 6348198 (2002-02-01), Schryvers et al.
patent: 6432412 (2002-08-01), Emery et al.
patent: 6682754 (2004-01-01), Emery et al.
patent: 6720160 (2004-04-01), Wolde-Mariam
patent: 6869607 (2005-03-01), Buschle et al.
patent: 6984503 (2006-01-01), Wang et al.
patent: 7026157 (2006-04-01), Stojiljkovic et al.
patent: 7138124 (2006-11-01), Emery et al.
patent: 7138125 (2006-11-01), Emery et al.
patent: 7147857 (2006-12-01), Emery et al.
patent: 7148191 (2006-12-01), Egyed et al.
patent: 7153527 (2006-12-01), Gradle et al.
patent: 7160549 (2007-01-01), Emery et al.
patent: 2003/0036639 (2003-02-01), Emery et al.
patent: 2003/0064073 (2003-04-01), Emery et al.
patent: 2003/0206922 (2003-11-01), Emery et al.
patent: 2003/0211118 (2003-11-01), Emery et al.
patent: 2004/0197350 (2004-10-01), Emery et al.
patent: 2004/0197869 (2004-10-01), Emery et al.
patent: 2004/0265329 (2004-12-01), Emery et al.
patent: 2005/0095682 (2005-05-01), Emery et al.
patent: 2005/0186217 (2005-08-01), Emery et al.
patent: 2006/0024323 (2006-02-01), Emery et al.
patent: 2006/0083753 (2006-04-01), Emery et al.
patent: 2006/0165718 (2006-07-01), Emery et al.
patent: 2006/0233824 (2006-10-01), Emery et al.
patent: 2006/0269564 (2006-11-01), Emery et al.
patent: 2007/0087011 (2007-04-01), Emery et al.
patent: 2007/0098733 (2007-05-01), Emery et al.
patent: 2029906 (1990-09-01), None
patent: 0 287 206 (1988-10-01), None
patent: 0 287 206 (1993-08-01), None
patent: 0 287 206 (1993-08-01), None
patent: WO 90/11349 (1990-10-01), None
patent: WO 90/12591 (1990-11-01), None
patent: WO 95/21627 (1995-08-01), None
patent: WO 96/01620 (1996-01-01), None
Bos et al, Current Opinion in Microbiology, 2004, 7:610-616.
Callaway et al, J. Diary Sci., 2005, 88:3603-3608.
Petsch et al., “Endotoxin removal from protein solutions,”Journal of Biotechnology, 76:97-119.
Acheson et al., “Protective Immunity to Shiga-Like Toxin I Following Oral Immunization with Shiga-Like Toxin I B-Subunit-ProducingVibrio choleraeCVD 103-HgR,”Infect. Immmun., Jan. 1996;64(1):355-357.
Alberti et al., “A porin fromKlebsiella pneumoniae: sequence homology, three-dimensional model, and complement binding,”Infect Immun. Mar. 1995,;63(3):903-910.
Alukar et al., “Immunomodulatory Properties of Porins of Some Members of the familyEnterobacteriaceae, ” Infection and Immunity, Jun. 1997; 65(6):2382-2388.
Ames, “Resolution of bacterial proteins by polyacrylamide gel electrophoresis on slabs. Membrane, soluble, and periplasmic fractions,”J Biol Chem. Jan. 25 1974; 249(2):634-644. (No abstract available.).
Anwar et al., “Antibody response to actuePseudomonas aeruginosainfection in a burn wound,”FEMS Microbiology Letters, 1985; 29:225-230.
Arockiasamy et al., “Purification of Integral Outer-Membrane Protein OmpC, a Surface Antigen fromSalmonella typhifor Structure-Function Studies: A Method Applicable to Enterobacterial Major Outer-Membrane Protein,”Analytical Biochemistry, 2000, 283:64-70.
Arp, “Response of turkeys toEscherichia coli,” Poultry Digest, pp. 142 and 146 (1994).
Ashkenazi et al., “Safety and Immunogenicity of Shigella Sonnei and Shigella Flexneri 2a O-specific Polysaccharide Conjugates in Children,”J. Infect. Dis., Jun. 1999;179(6):1565-1568.
Ausubel et al., eds.,Current Protocols in Molecular Biology, John Wiley & Sons, Inc., 1998; cover pg., publication pg., and table of contents only (12 pgs.).
Babu et al., “Effects of Live Attenuated and KilledSalmonellaVaccine on T-Lymphocyte Mediated Immunity in Laying Hens,”Vet. Immunol. Immunopathol., Jan. 10, 2003;(1):39-44.
Banerjee-Bhatnagar et al., “Expression ofNeisseria meningitidisiron-regulated outer membrane proteins, including a 70-kilodalton transferrin receptor, and their potential for use as vaccines,”Infect Immun. Sep. 1990; 58(9):2875-2881.
Bannerman et al., “The bovine innate immune respone during experimentally inducedPseudomonas aeruginosamastitis,”Vet. Immunopathol., 2005, 107:201-215.
Bokete et al., “Genetic and Phenotypic Analysis ofEscherichia coliwith Enteropathogenic Characteristics Isolated from Seattle Children,”J. Infect. Dis., Jun. 1997;175(6):1382-1389.
Bolin et al., “Passive Immunization with Antibodies Against Iron-Regulated Outer Membrane Proteins Protects Turkeys fromEscherichia coliSepticemia,”Infect Immun., May, 1987;55(5):1239-1242.
Boothby et al., “Characterization of antigens from mycoplasmas of animal origin,”Am J Vet Res. Mar. 1983; 44(3):433-439.
Bosworth et al., “Vaccination with Genetically Modified Shiga-Like Toxin IIe Prevents Edema Disease in Swine,”Infect. Immun., Jan. 1996;64(1):55-60.
Bouchet et al., “Immunological variants of the aerobactin-cloacin DF13 outer membrane protein receptor IutA among enteric bacteria,”Infect Immun. Jul. 1994;62(7):3017-3021.
Bradley, “Bovine Mastitis: An Evolving Disease,”Vet. Journal, 2002, 164/2:116-128.
Bragg et al., “Organization of proteins in the native and reformed outer membrane ofEscherichia coli,” Biochim Biophys Acta. Aug. 9, 1972;274(2):478-488. (No abstract available).
Brogden et al., “Lysates of turkey-grownPasteurella multocida: effects of solubilizing agents on the immunologic properties of membrane vesticles,”Am J Vet. Res. Mar 1983;44(3):428-432.
Bruckmaier et al., “Changes of physiochemical indicators during mastitis and the effects of milk ejection on their sensitivity,”J. Dairy Res., 2004, 71/3:316-321 (abstract only).
Bruckmaier et al., “Immunomediator and milk protein gene expression in mammary tissue during endotoxin-induced mastitis,”Livestock Production Science, 2005; 98(1/2):81-97, abstract only (1 pg).
Burvenich et al., “Severity ofE. colimastitis is mainly determined by cow factors,”Vet. Res., 2003; 34;521-564.
Butterton et al., “Coexpression of the B Subunit of Shiga Toxin 1 and EaeA from EnterohemorrhagicEscherichia coliinVibrio choleraevaccine Strains,”Infect. Immun., Jun. 1997;65(6):2127-2135.
Calnek et al., Diseases of Poultry-9th ed., pp. 99-130, Iowa StateUniversity, Ames Iowa (1991).
CDC National Antimicrobial Resistance Monitoring System:Enteric Bacteria, available at www.cdc.gov
arms/.
CDCSalmonellaSurveillance: Annual Summary, 2002. Atlanta, GA: US Department of Health and Human Services, CDC, 2003.
CDCShigellaSurveillance: Annual Summary, 2002. Atlanta, GA: US Department of Health and Human Services, CDC, 2003.
Charles et al., “Adjuvanted Subunit Vaccines for the Control ofSalmonella enteritidisInfection in Turkeys,”Am. J. Vet. Res., May 1994;55(5):636-642.
Chart et al., “Antigenic and Molecular Homology of the Ferric Enterobactin Receptor Protein ofEscherichia coli,”J. Gen. Microbiol.,

Affiliated with

Also associated with

Rating

Methods for reducing fecal shedding does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for reducing fecal shedding, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for reducing fecal shedding will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2805374